Julie Mouchet is a Pharmacoepidemiologist, currently Global Direction, Evidence Generation at Novartis. She previously held positions of Global Real World Evidence Lead at Novartis and at Roche, where she was a key member of several drug programs in Neuroscience and Rare Diseases. She holds a Master’s degree in Clinical Development of health products from the University of Lyon, France, and PhD in Pharmacoepidemiology from the University of Bordeaux, France.
